Ilika moves closer to commercialising its large‑format solid‑state batteries

Ilika Plc

The recent progress at Ilika points to a company actively positioning itself for commercial relevance in the electric vehicle supply chain. While many solid‑state battery concepts remain stuck in the lab, Ilika’s Goliath programme is beginning to show the kind of practical advances that matter to OEMs and long‑term investors alike.

The Goliath programme focuses on developing large‑format pouch cells using solid‑state technology built around a solid ceramic electrolyte and a high‑energy silicon anode. This combination allows for improved thermal stability, greater energy density, and potentially faster charging.

In April 2025, Ilika confirmed that cells manufactured using production‑grade equipment at the UK Battery Industrialisation Centre achieved higher yields and faster charge performance than earlier prototypes. It means the company is now working with equipment and processes that mirror commercial settings, rather than relying on lab tools. As part of its roadmap, Ilika is building a 1.5 MWh pre‑commercial production line, which will supply evaluation cells to automotive partners and Tier 1 suppliers.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika completes PRIMED programme with improved Goliath battery performance

Ilika has completed its £3 million PRIMED programme, reporting improved energy density, charging, power, cycle life and thermal stability for its 10Ah Goliath solid-state battery cells, alongside new commercial opportunities in defence, e-bikes and other applications.

Ilika to present UK-developed quasi-solid-state cell technology at Faraday Event

Ilika will present its UK-developed quasi-solid-state cell technology at The Faraday Institution’s Next Frontiers in Energy Storage event on Tuesday 8 September.

Ilika targets MedTech adoption with Stereax solid-state batteries

Ilika is targeting medical device and IoT applications with its Stereax miniature solid-state batteries, supported by a manufacturing and commercialisation agreement with Cirtec Medical.

Ilika confirms AGM date and Annual Report posting

Ilika has given notice of its 2026 Annual General Meeting and said its annual report and AGM notice will be available shortly.

Ilika targets medical device opportunities with Stereax at MedTech Ireland

Ilika’s Stereax technology will be presented at MedTech Ireland 2026 as the company targets further opportunities in active implanted medical devices.

Search